Tandem Diabetes Care Inc
NASDAQ:TNDM
Tandem Diabetes Care Inc
NASDAQ:TNDM
Price:
37.51 USD
6.44%
Market Closed
Updated:
Apr 29, 2024
Tandem Diabetes Care Inc
Cash from Financing Activities
|
Tandem Diabetes Care Inc
Cash from Financing Activities Peer Comparison
Comparables:
BDX
BSX
SYK
ABT
ISRG
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Tandem Diabetes Care Inc
NASDAQ:TNDM
|
Cash from Financing Activities
$4.1m
|
CAGR 3-Years
-76%
|
CAGR 5-Years
-49%
|
CAGR 10-Years
-31%
|
|
|
Becton Dickinson and Co
NYSE:BDX
|
Cash from Financing Activities
-$2.3B
|
CAGR 3-Years
-144%
|
CAGR 5-Years
4%
|
CAGR 10-Years
-10%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Cash from Financing Activities
$5m
|
CAGR 3-Years
-74%
|
CAGR 5-Years
-68%
|
CAGR 10-Years
N/A
|
|
|
Stryker Corp
NYSE:SYK
|
Cash from Financing Activities
-$1.6B
|
CAGR 3-Years
-425%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Abbott Laboratories
NYSE:ABT
|
Cash from Financing Activities
-$7.1B
|
CAGR 3-Years
-33%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-9%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Cash from Financing Activities
$46.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-13%
|
CAGR 10-Years
N/A
|
See Also
What is Tandem Diabetes Care Inc's Cash from Financing Activities?
Cash from Financing Activities
4.1m
USD
4.1m
USD
Based on the financial report for Dec 31, 2023, Tandem Diabetes Care Inc's Cash from Financing Activities amounts to 4.1m USD.
What is Tandem Diabetes Care Inc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 10Y
-31%
-31%
Over the last year, the Cash from Financing Activities growth was -76%. The average annual Cash from Financing Activities growth rates for Tandem Diabetes Care Inc have been -76% over the past three years , -49% over the past five years , and -31% over the past ten years .
You don't have any saved screeners yet
